These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29771635)

  • 1. Pathogenesis-based treatments in primary Sjogren's syndrome using artificial intelligence and advanced machine learning techniques: a systematic literature review.
    Foulquier N; Redou P; Le Gal C; Rouvière B; Pers JO; Saraux A
    Hum Vaccin Immunother; 2018; 14(11):2553-2558. PubMed ID: 29771635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can artificial intelligence replace manual search for systematic literature? Review on cutaneous manifestations in primary Sjögren's syndrome.
    Orgeolet L; Foulquier N; Misery L; Redou P; Pers JO; Devauchelle-Pensec V; Saraux A
    Rheumatology (Oxford); 2020 Apr; 59(4):811-819. PubMed ID: 31504928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New biological therapies in Sjögren's syndrome.
    Nocturne G; Cornec D; Seror R; Mariette X
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):783-93. PubMed ID: 27107513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.
    Lodde BM; Baum BJ; Tak PP; Illei G
    Ann Rheum Dis; 2006 Nov; 65(11):1406-13. PubMed ID: 16880196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting primary Sjögren's syndrome.
    Odani T; Chiorini JA
    Mod Rheumatol; 2019 Jan; 29(1):70-86. PubMed ID: 30424703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bibliography. Current world literature. Systemic lupus erythematosus and Sjögren's syndrome.
    Curr Opin Rheumatol; 1999 Sep; 11(5):B147-68. PubMed ID: 10503670
    [No Abstract]   [Full Text] [Related]  

  • 7. Unmasking the pathogenic role of IL-17 axis in primary Sjögren's syndrome: a new era for therapeutic targeting?
    Alunno A; Carubbi F; Bartoloni E; Bistoni O; Caterbi S; Cipriani P; Giacomelli R; Gerli R
    Autoimmun Rev; 2014 Dec; 13(12):1167-73. PubMed ID: 25183242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis.
    Zhang LW; Zhou PR; Wei P; Cong X; Wu LL; Hua H
    Scand J Immunol; 2018 Apr; 87(4):e12649. PubMed ID: 29476557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome.
    Jonsson R; Haga HJ; Gordon TP
    Scand J Rheumatol; 2000; 29(6):341-8. PubMed ID: 11132201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological therapies in primary Sjögren's syndrome.
    Ng WF; Bowman SJ
    Expert Opin Biol Ther; 2011 Jul; 11(7):921-36. PubMed ID: 21457124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome -- managing oral and systemic symptoms via a multi-disciplinary approach.
    Hamburger J
    Oral Dis; 2004 Sep; 10(5):306-9. PubMed ID: 15315649
    [No Abstract]   [Full Text] [Related]  

  • 12. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
    Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
    J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The overlap of primary Sjögren's syndrome with antiphospholipid syndrome in man: case report].
    Wielosz E; Majdan M; Koszarny A; Zychowska I
    Pol Arch Med Wewn; 2007; 117 Suppl():76-8. PubMed ID: 18778028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diseases and Sjogren's syndrome: an autoimmune exocrinopathy.
    Fox PC
    Ann N Y Acad Sci; 2007 Mar; 1098():15-21. PubMed ID: 17332090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One year in review 2018: Sjögren's syndrome.
    Argyropoulou OD; Valentini E; Ferro F; Leone MC; Cafaro G; Bartoloni E; Baldini C
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):14-26. PubMed ID: 30156536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sjögren's syndrome and deficiency of ICA69.
    Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
    Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary Sjögren's syndrome--more than a dry mouth and dry eyes].
    Magnus JH; Omdal R; Hinderaker W; Husby G
    Nord Med; 1990; 105(10):262-3. PubMed ID: 2235472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjogren's thrombocytopenia.
    Kamath V; Prabhakar B; Veena ; Lachikarathman D
    J Assoc Physicians India; 2011 Feb; 59():114-5. PubMed ID: 21751649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches to the treatment of Sjögren's syndrome: soon beyond symptomatic relief?
    Steinfeld S; Simonart T
    Dermatology; 2003; 207(1):6-9. PubMed ID: 12835540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for the treatment of Sjögren's syndrome.
    Valim V; Trevisani VF; Pasoto SG; Serrano EV; Ribeiro SL; Fidelix TS; Vilela VS; Prado LL; Tanure LA; Libório-Kimura TN; Brito Filho OH; Barros LA; Miyamoto ST; Lourenço SV; Santos MC; Vieira LA; Adán CB; Bernardo WM
    Rev Bras Reumatol; 2015; 55(5):446-57. PubMed ID: 26360421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.